SPDR S&P Pharmaceuticals ETF (XPH)
40.37
+0.53
(+1.33%)
USD |
NYSEARCA |
May 08, 13:19
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.35% | 0.08% | 137.34M | 58902.67 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.49% | 61.00% | -56.13M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to replicate the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Pharmaceuticals Select Industry Index, which is comprised of 21 stocks. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | State Street Global Advisors |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 08, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.06% |
| Stock | 99.87% |
| Bond | 0.07% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to replicate the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Pharmaceuticals Select Industry Index, which is comprised of 21 stocks. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | State Street Global Advisors |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |